Navigation Links
Oncolytics Biotech Inc. Announces 2008 First Quarter Results
Date:4/30/2008

igates its exposure to credit risk by restricting its

portfolio to investment grade securities with short term maturities and

by monitoring the credit risk and credit standing of counterparties.

Interest rate risk

Interest rate risk is the risk that future cash flows of a financial

instrument will fluctuate because of changes in market interest rates.

The Company is exposed to interest rate risk through its cash and cash

equivalents and its portfolio of short-term investments. The Company

mitigates this risk through its investment policy that only allows

investment of its excess cash resources in investment grade vehicles

while matching maturities with the Company's operational requirements.

Fluctuations in market rates of interest do not have a significant impact

on the Company's results of operations due to the short term to maturity

of the investments held.

Currency risk

Currency risk is the risk that future cash flows of a financial

instrument will fluctuate because of changes in foreign exchange rates.

The Company is exposed to currency risk from the purchase of goods and

services primarily in the U.S. and the U.K. The Company mitigates its

foreign exchange risk through the purchase of foreign currencies in

sufficient amounts to settle its foreign accounts payable.

Balances in foreign currencies at March 31, 2008 are as follows:


'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 05, 2015 Hayden-McNeil is ... develop custom course materials for smaller courses. This program ... low as 200 students. , “I’m very excited ... of higher education instructors,” said Jeff McCarthy, Hayden-McNeil president. ... can do our part to make education both more ...
(Date:5/5/2015)... , May 5, 2015  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, has ... independent analysis designed to reflect the healthcare patterns ... This model will be used to characterize the ... could have on those groups of patients and ...
(Date:5/5/2015)... Franz Inc ., the leading supplier of Semantic ... AllegroGraph, has been named a Champion by Bloor Research in ... AllegroGraph is a high performance Semantic Graph Database that enables ... skyrocketing in popularity and have grown by 400% in the ... by DB-Engines. , “We are excited that Graph and ...
(Date:5/5/2015)...   Tocagen Inc. , a clinical-stage immuno-oncology ... , M.D., a venture partner at New Enterprise ... of directors of Tocagen. Dr. Parkinson has more ... development, including leading clinical activities at Amgen and ... cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and Vectibix®, ...
Breaking Biology Technology:Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 2Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... Pa., Dec. 12 Genaera,Corporation (Nasdaq: GENR ) ... of Genaera, is scheduled to present at the 2007,RBC ... an,RBC Capital Markets, panel discussion of diabetes and obesity, ... take place in,New York on Thursday, December 13 at ...
... 12 Biomoda, Inc. (OTC,Bulletin Board: BMOD) ( ... of Mining and Technology (New Mexico Tech at, ... on clinical,studies and the development of specialized image ... its assay for the early,detection of lung cancer., ...
... Inc. (Nasdaq:,INSM), today announced that it has been ... Association (MDA). The grant is expected to cover ... Insmed,s 24-week,Phase 3 enabling trial in patients with ... stage biopharmaceutical company with extensive,expertise in biologics and ...
Cached Biology Technology:Biomoda Announces Collaborative Agreement With New Mexico Tech 2Insmed Awarded $2.1 Million by Muscular Dystrophy Association 2Insmed Awarded $2.1 Million by Muscular Dystrophy Association 3
(Date:5/5/2015)... OXFORD, Conn. , May 5, 2015, NXT-ID, ... biometric authentication company focused on the growing mobile commerce market, ... the Company,s Chief Technology Officer, is presenting  at CARTES SECURE ... May 5-7, 2015. The three-day conference ... session David is speaking in is themed Global Fraud: ...
(Date:4/27/2015)... 2015  For more than four decades, AUVSI,s ... the premier worldwide event for the unmanned land, sea, ... event for any local, national, or trade news organization ... markets and current applications of unmanned technologies. The conference ... $48 billion industry, and how it will soon impact ...
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... shipping to pre-order customers the first week of May, ... the month of May. Gino ... significant milestone for the company as Wocket® enters the ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... Mo. Millions of post-menopausal women use hormone replacement ... with menopause. In a recent University of Missouri study, ... HRT, a synthetic progestin, could be a major factor ... researchers have compelling evidence that using an antibody that ...
... be wondering: Will April be the cruelest month? , ... this spring are eerily reminiscent of 1993 and 1994, back-to-back years ... $20 billion of economic damage, damaging and destroying more than 50,000 ... Parallels this year include abnormally ...
... diabetes be prevented before birth? According to Jonathan ... Pediatrics and Professor of Genetics at the Washington University ... are already genetically encoded in individuals while still in ... and prevent diseases in infancy. ...
Cached Biology News:MU researcher links hormone replacement therapy to breast cancer 2Geologist decries floodplain development 2Geologist decries floodplain development 3Leading pediatrician addresses the future of children's health 2
... based purification systems provide high speed purification ... They offer increased throughput and reproducible results. ... KingFisher mL and KingFisher 96, covering sample ... system consists of an instrument, specially designed ...
Candida (IgA) -Ab EIA Sample Size: 5 l...
... Principle: The Oxidized LDL Competitive ELISA ... LDL in the sample competes with a fixed ... well for the binding of the biotin- labeled ... 25 l The Oxidized LDL Competitive ...
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
Biology Products: